These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25167944)

  • 1. Treatment of Helicobacter pylori infection 2014.
    O'Connor A; Vaira D; Gisbert JP; O'Morain C
    Helicobacter; 2014 Sep; 19 Suppl 1():38-45. PubMed ID: 25167944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Helicobacter pylori infection 2013.
    O'Connor A; Molina-Infante J; Gisbert JP; O'Morain C
    Helicobacter; 2013 Sep; 18 Suppl 1():58-65. PubMed ID: 24011247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
    Zhang M; Chen CY; Wang XT; Lyu B
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Helicobacter pylori Infection 2015.
    O'Connor A; Gisbert JP; O'Morain C; Ladas S
    Helicobacter; 2015 Sep; 20 Suppl 1():54-61. PubMed ID: 26372826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward population specific and personalized treatment of Helicobacter pylori infection.
    Liou JM; Chen PY; Kuo YT; Wu MS;
    J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Helicobacter pylori infection 2017.
    O'Connor A; Lamarque D; Gisbert JP; O'Morain C
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Helicobacter pylori infection 2016.
    O'Connor A; Fischbach W; Gisbert JP; O'Morain C
    Helicobacter; 2016 Sep; 21 Suppl 1():55-61. PubMed ID: 27531541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori.
    Wu TS; Hsu PI; Kuo CH; Hu HM; Wu IC; Wang SSW; Chen YH; Wu DC; Su WW; Kuo FC
    J Dig Dis; 2017 Sep; 18(9):537-542. PubMed ID: 28644575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
    Marin AC; Nyssen OP; McNicholl AG; Gisbert JP
    Drugs; 2017 May; 77(7):765-776. PubMed ID: 28361211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection].
    Kim SB; Lee SH; Kim KO; Jang BI; Kim TN
    Korean J Gastroenterol; 2015 Nov; 66(5):261-7. PubMed ID: 26586348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Helicobacter pylori - 2012].
    Buzás GM
    Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
    Gisbert JP; Romano M; Gravina AG; Solís-Muñoz P; Bermejo F; Molina-Infante J; Castro-Fernández M; Ortuño J; Lucendo AJ; Herranz M; Modolell I; Del Castillo F; Gómez J; Barrio J; Velayos B; Gómez B; Domínguez JL; Miranda A; Martorano M; Algaba A; Pabón M; Angueira T; Fernández-Salazar L; Federico A; Marín AC; McNicholl AG
    Aliment Pharmacol Ther; 2015 Apr; 41(8):768-75. PubMed ID: 25703120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Treatment of Helicobacter pylori Infection 2019.
    O'Connor A; Liou JM; Gisbert JP; O'Morain C
    Helicobacter; 2019 Sep; 24 Suppl 1():e12640. PubMed ID: 31486235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori.
    Malfertheiner P; Selgrad M
    Curr Opin Gastroenterol; 2014 Nov; 30(6):589-95. PubMed ID: 25268839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.